News Detail

Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price

PUBT · 2d ago

Listen to the news

Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price

Moleculin Biotech priced a $9.3 million best-efforts public offering bundled with Common Warrants to buy up to 37,130,001 shares.
Common Warrants become immediately exercisable at USD 0.75 per share, expiring five years from the initial exercise date.
Offering includes 12,376,667 common shares or pre-funded warrants at a combined price of USD 0.75 with associated warrants.
Net proceeds earmarked to advance Annamycin clinical development, support working capital; closing expected around Aug. 3, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607311012PRIMZONEFULLFEED9801649) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.